0001209191-15-056868.txt : 20150626
0001209191-15-056868.hdr.sgml : 20150626
20150626171446
ACCESSION NUMBER: 0001209191-15-056868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150625
FILED AS OF DATE: 20150626
DATE AS OF CHANGE: 20150626
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KEMPHARM, INC
CENTRAL INDEX KEY: 0001434647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205894398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 CROSSPARK ROAD, SUITE 100
CITY: CORALVILLE
STATE: IA
ZIP: 52241
BUSINESS PHONE: 319-665-2575
MAIL ADDRESS:
STREET 1: 2656 CROSSPARK ROAD, SUITE 100
CITY: CORALVILLE
STATE: IA
ZIP: 52241
FORMER COMPANY:
FORMER CONFORMED NAME: KEMPHARM INC
DATE OF NAME CHANGE: 20080507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Gordon K
CENTRAL INDEX KEY: 0001638367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36913
FILM NUMBER: 15956002
MAIL ADDRESS:
STREET 1: 2656 CROSSPARK ROAD
STREET 2: SUITE 100
CITY: CORALVILLE
STATE: IA
ZIP: 52241
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-25
0
0001434647
KEMPHARM, INC
KMPH
0001638367
Johnson Gordon K
C/O KEMPHARM, INC.
2656 CROSSPARK ROAD, SUITE 100
CORALVILLE
IA
52241
0
1
0
0
Chief Business Officer
Stock Option (right to buy)
18.29
2015-06-25
4
A
0
160000
0.00
A
2025-06-24
Common Stock
160000
160000
D
Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the total shares subject to the option vest in equal annual installments beginning on June 25, 2016 through June 25, 2019, provided, that in the event that the Company terminates the Reporting Person's employment without Cause or for Good Reason three (3) months prior to or within twelve (12) months following a Change in Control (as defined in the Plan), then the option shall become fully vested and immediately exercisable as of such date. The option expires ten years after the date of grant.
/s/ Matthew P. Dubofsky, Attorney-in-Fact
2015-06-26